HealthCare Institute of New Jersey Statement on Second Round of IRA Price Controls
Trenton, January 17, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the second round of government-imposed price controls on life-saving medicines announced by the Department of Health and Human Services. “There are smart and efficient ways to lower health care costs with […]
HealthCare Institute of New Jersey Statement on the FTC Report on PBMs
Trenton, January 15, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning yesterday’s second report issued by the Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs), which found they charge significant markups for medicines treating serious conditions including cancer, multiple sclerosis, HIV, […]
HealthCare Institute of New Jersey Announces Kyle Sullender as Director of Government and External Relations
Kyle Sullender, Director of Government and External Relations Trenton, NJ – December 19, 2024 – HealthCare Institute of New Jersey President and Chief Executive Officer Chrissy Buteas announced the expansion of the HINJ team with the hiring of Kyle Sullender, who will serve as Director of Government and External Relations. “I am delighted to welcome […]
HealthCare Institute of New Jersey and Organon Held “Advancing Women’s Health” Forum, Featuring First Lady Tammy Murphy, Congresswoman Bonnie Watson Coleman and Department of Human Services Commissioner Sarah Adelman
Trenton, December 17, 2024 ― The HealthCare Institute of New Jersey and Organon (www.organon.com), with premier sponsor Novartis and supporting sponsor Ferring, hosted a forum on December 16 titled “Advancing Women’s Health” – a half-day seminar highlighting New Jersey’s life sciences’ commitment to women’s health and innovating new medical advances and treatments for women. Read […]
HINJ President and CEO Chrissy Buteas Interviewed by Steve Adubato on State of Affairs Show
HINJ President and CEO Chrissy Buteas was recently interviewed by Steve Adubato on his State of Affairs show to discuss New Jersey’s life sciences and our contributions to global human health and our state’s workforce and economy. The interview can be found here.
Op-Ed: Protect Future Cures While Lowering Cost of Health Care
An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. New Prescription Drug Affordability Council must take a balanced approach that helps patients without harming potential cures The cost of health care is a critical issue — for patients, for families and loved ones, and for businesses and governments. It can often mean the […]
Op Ed/Editorial Response: “New Jersey’s Life Sciences Might Have Saved Your Grandmother’s Life”
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) Trenton, October 31, 2024 ― I write in response to your editorial published on October 27. The piece was unfortunate in its significant misrepresentation and vastly oversimplified portrayal of one of the most transformative and life-saving industries in human history – the […]
HealthCare Institute of New Jersey Statement on Assembly Bill A-4953, the Patient and Provider Protection Act
Trenton, October 24, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning Assembly Bill A-4953, the Patient and Provider Protection Act: “The House Energy and Commerce Committee, the Federal Trade Commission (FTC), the Wall Street Journal and the New York Times have all […]
HealthCare Institute of New Jersey Statement on the Senate Legislative Oversight Committee’s AI Hearing
Trenton, October 21, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s Senate Legislative Oversight Committee Hearing entitled, “How artificial intelligence (AI) is defined and the AI landscape in New Jersey.” “New Jersey and our state’s innovation ecosystem are at the forefront […]
HealthCare Institute of New Jersey Statement on the Prescription Drug Affordability Council
Trenton, October 11, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the State’s recent completion of appointments to the Prescription Drug Affordability Council (PDAC): “Drug development is an extraordinarily complex and multifaceted journey, with middlemen in the supply chain – such as […]